Literature DB >> 2069856

An estimate of the heritable fraction of childhood cancer.

S A Narod1, C Stiller, G M Lenoir.   

Abstract

We have reviewed the records of the 16,564 cases of childhood cancer diagnosed from 1971 to 1983 which were reported to the National Registry of Childhood Tumours in Great Britain for the presence of underlying genetic disease in order to estimate the proportion which results from inherited mutations. A genetic condition was listed for 509 patients, or 3.07% of the total number of tumours. The most frequently recorded diagnoses were: bilateral retinoblastoma (162 cases); Down syndrome (135); neurofibromatosis (90); hereditary Wilms' tumour (71); and tuberous sclerosis (20). The highest hereditary fractions at individual tumour sites were seen for: retinoblastoma (37.2%); kidney (7.2%); leukaemia (2.6%) and brain and spinal cord (2.0%). When information about family history from published reports was incorporated into the figures calculated from Registry data the total genetic fraction was estimated to be 4.2%. We conclude that there is a clear genetic basis for a small minority of the cancers of childhood, but ethnic variation and the lack of known environmental determinants suggest that the total influence of heredity may be higher.

Entities:  

Mesh:

Year:  1991        PMID: 2069856      PMCID: PMC1972537          DOI: 10.1038/bjc.1991.216

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  49 in total

1.  Neurofibromatosis and childhood tumors.

Authors:  J Blatt; R Jaffe; M Deutsch; J C Adkins
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

2.  Medical and drug risk factors associated with neuroblastoma: a case-control study.

Authors:  S Kramer; E Ward; A T Meadows; K E Malone
Journal:  J Natl Cancer Inst       Date:  1987-05       Impact factor: 13.506

3.  Association between hepatoblastoma and polyposis coli.

Authors:  J E Kingston; A Herbert; G J Draper; J R Mann
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

4.  Hepatoblastoma in families with polyposis coli.

Authors:  F P Li; W A Thurber; J Seddon; G E Holmes
Journal:  JAMA       Date:  1987-05-08       Impact factor: 56.272

5.  Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus.

Authors:  M H Greene; L R Goldin; W H Clark; E Lovrien; K H Kraemer; M A Tucker; D E Elder; M C Fraser; S Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Tuberous sclerosis: a new estimate of prevalence within the Oxford region.

Authors:  A Hunt; R H Lindenbaum
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

7.  Epidemiological investigations on neuroblastomas in Denmark 1943-1980.

Authors:  N L Carlsen
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

8.  Excess risk of breast cancer in the mothers of children with soft tissue sarcomas.

Authors:  J M Birch; A L Hartley; H B Marsden; M Harris; R Swindell
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

9.  Second primary neoplasms in patients with retinoblastoma.

Authors:  G J Draper; B M Sanders; J E Kingston
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

10.  Breast cancer risk in mothers of children with osteosarcoma and chondrosarcoma.

Authors:  A L Hartley; J M Birch; H B Marsden; M Harris
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

View more
  56 in total

Review 1.  Tuberous Sclerosis Complex with Multiple Gastrointestinal Manifestations. Case Report and Literature Review.

Authors:  Tariq A Hammad; Yaseen Alastal; Muhammad Ali Khan; Soukayna Rkaine; Thomas C Sodeman; Ali Nawras
Journal:  J Gastrointest Cancer       Date:  2016-12

2.  New RB1 oncogenic mutations and intronic polymorphisms in Serbian retinoblastoma patients: genetic counseling implications.

Authors:  Milica Kontic; Iciar Palacios; Ángelo Gámez; Isabel Camino; Zoran Latkovic; Dejan Rasic; Vera Krstic; Vera Bunjevacki; Javier Alonso; Ángel Pestaña
Journal:  J Hum Genet       Date:  2006-09-14       Impact factor: 3.172

3.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

4.  Full breastfeeding and paediatric cancer.

Authors:  Juan A Ortega-García; Josep Ferrís-Tortajada; Alberto M Torres-Cantero; Offie P Soldin; Encarna Pastor Torres; Jose L Fuster-Soler; Blanca Lopez-Ibor; Luis Madero-López
Journal:  J Paediatr Child Health       Date:  2007-11-12       Impact factor: 1.954

5.  Tongue carcinoma in an adult Down's syndrome patient: a case report.

Authors:  Fadi S Farhat; Fady Geara; Mohamed Natout; Jamal Serhal; Walid Daya
Journal:  World J Surg Oncol       Date:  2009-03-04       Impact factor: 2.754

6.  Congenital anomalies and childhood cancer in Great Britain.

Authors:  S A Narod; M M Hawkins; C M Robertson; C A Stiller
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

7.  Prenatal and perinatal risk factors for neuroblastoma.

Authors:  Elizabeth Bluhm; Dawn Elizabeth McNeil; Sven Cnattingius; Gloria Gridley; Laure El Ghormli; Joseph F Fraumeni
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

Review 8.  Advances in the Treatment of Pediatric Bone Sarcomas.

Authors:  Patrick J Grohar; Katherine A Janeway; Luke D Mase; Joshua D Schiffman
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 9.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

10.  Childhood solid tumours in relation to population mixing around the time of birth.

Authors:  T A Nyari; H O Dickinson; D M Hammal; L Parker
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.